VERA

Conviction 12HealthcareScan · Mon, Aug 10, 2026

VERA$31.59-3.95%

ResistanceSupportVol 14Insider sell

Vol MA14 2.09M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Vera Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.veratx.com ↗

Price31.59

Change-3.95%

Gap-1.55%

Rel volume0.89×

Avg volume1.96M

Avg $ vol67.61M

SMA 2035.02

SMA 5036.39

SMA 20038.96

Price vs 50-13.20%

Price vs 200-18.92%

MA stackbearish

50/200 cross—

Supertrenddown · 36.28

RSI (14)37

MACD hist-0.31

MACD cross—

Stoch %K / %D26 / 31

ADX (14)34

+DI / −DI14 / 30

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.22%

ADR %5.17%

52w high55.67

52w low19.79

From 52w high-43.25%

Above 52w low+59.63%

New 52w highNo

SqueezeOff

Bollinger width41.53%

%B0.26

Donchian pos15.02%

Donchian high43.19

Donchian low29.54

AVWAP (52w high)39.75

vs AVWAP high-20.54%

AVWAP (52w low)35.72

vs AVWAP low-11.55%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d0.89×

Avg vol (14d)2.09M

Avg vol (20d)1.96M

Avg $ vol (20d)67.61M

Market cap—

RS 3m (vs SPY)-14.03%

RS 6m (vs SPY)-33.80%

RS line new highNo

Trend template3/8

Technical rank14.6

1 week-1.99%

1 month-24.79%

3 months-12.71%

6 months-27.38%

1 year+60.19%

YTD-35.03%

P/E-7.87

P/B4.72

P/S—

P/FCF-9.76

EPS-4.66

Div yield—

ROE-59.96%

ROA-48.19%

Debt/Eq0.15

Current13.64

EV/EBITDA-7.36

Gross margin—

Net margin—

Rev growth—

EPS growth-96.92%

Price target82.08

Target upside149.79%

Analyst ratingBuy

Institutional109.15%

Ent. value2.32B

Revenue—

Net income-121.03M

Gross profit—

Free cash flow-241.73M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.78M

Employees339

ListedFri, May 14, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank14.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance44.74

Support31.24

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VERA

All disclosures →

No recent disclosed trades by Congress in VERA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VERA · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Boman Nancy Lee Chief Regulatory Officer · Class A Common Stock · 2026-08-03	Grant	44.99K	—	2026-08-03	2026-08-05
Boman Nancy Lee Chief Regulatory Officer · Stock Option (right to buy) · 2026-08-03	Grant	63.01K	—	2026-08-03	2026-08-05
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-07-07	Sell	1K	$41K	2026-07-07	2026-07-09
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-07-07	Sell	32.55K	$1.4M	2026-07-07	2026-07-09
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-07-07	Sell	10.5K	$450K	2026-07-07	2026-07-09
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-07-07	Sell	2.2K	$96K	2026-07-07	2026-07-09
Cheng Andrew Director · Stock Option (right to buy) · 2026-05-21	Grant	17.08K	$0	2026-05-21	2026-05-26
Hall Kimball Director · Stock Option (right to buy) · 2026-05-21	Grant	17.08K	$0	2026-05-21	2026-05-26
MORRISSEY MICHAEL Director · Stock Option (right to buy) · 2026-05-21	Grant	17.08K	$0	2026-05-21	2026-05-26
Oliger Christy J. Director · Stock Option (right to buy) · 2026-05-21	Grant	17.08K	$0	2026-05-21	2026-05-26

SEC filings

EDGAR filings in VERA · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.